*Press releases are taken from the company websites.
*Titles may be translated independently.
*Please be aware that, since data is collected automatically, there is a possibility of omissions occurring.
*We would like to kindly inform you that we do not collect all press releases from companies.
| Ticker Code | Date | Title | Link |
|---|---|---|---|
| TSE:4530 | 6/18/2025 | New capacity of 18mL (17.28g) added to the treatment of primary palmar hyperhidrosis, "Apohide® Lotion 20%" - Notice of approval to obtain approval | https://www.hisamitsu.co.jp/company/pdf/news_release_250618.pdf |
| TSE:4552 | 6/18/2025 | Mucopolysaccharide type II video released for the "The Next Frontier" series produced by BBC StoryWorks Commercial Productions | https://ssl4.eir-parts.net/doc/4552/tdnet/2640224/00.pdf |
| TSE:4901 | 6/18/2025 | "FUJIFILM PROJECTOR ZUH6000" New Release (Fujifilm) | https://www.fujifilm.com/jp/ja/news/list/12423 |
| ABBV | 6/18/2025 | AbbVie Announces New Data Demonstrating Atogepant (QULIPTA® / AQUIPTA®) Achieves Superiority Across All Endpoints in Phase 3 Head-to-Head Study Compared to Topiramate for Migraine Prevention | https://news.abbvie.com/2025-06-18-AbbVie-Announces-New-Data-Demonstrating-Atogepant-QULIPTA-R-AQUIPTA-R-Achieves-Superiority-Across-All-Endpoints-in-Phase-3-Head-to-Head-Study-Compared-to-Topiramate-for-Migraine-Prevention |
| AMGN | 6/18/2025 | AMGEN'S PHASE 2 MARITIDE DATA TO BE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS | https://www.amgen.com/newsroom/press-releases/2025/06/amgens-phase-2-maritide-data-to-be-presented-at-the-american-diabetes-association-85th-scientific-sessions |
| BIIB | 6/18/2025 | Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia | https://investors.biogen.com/news-releases/news-release-details/biogen-initiates-phase-3-pediatric-study-omaveloxolone-treatment |
| MRK | 6/18/2025 | IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer | https://www.merck.com/news/ideate-prostate01-phase-3-trial-of-ifinatamab-deruxtecan-initiated-in-patients-with-pretreated-metastatic-castration-resistant-prostate-cancer/ |
| TSE:4568 | 6/17/2025 | Selected as "Digital Transformation Stocks (DX Stocks) 2025" for three consecutive years | https://www.daiichisankyo.co.jp/media/news_release/detail/index_7279.html |
| BMY | 6/17/2025 | Bristol Myers Squibb Announces Dividend | https://news.bms.com/news/corporate-financial/2025/Bristol-Myers-Squibb-Announces-Dividend-54d68b0a2/default.aspx |
| JNJ | 6/17/2025 | Johnson & Johnsonseeks U.S. FDA approval of STELARA® (ustekinumab) for the treatment of pediatric Crohn’s disease | https://www.jnj.com/media-center/press-releases/johnson-johnson-seeks-u-s-fda-approval-of-stelara-ustekinumab-for-the-treatment-of-pediatric-crohns-disease |
| JNJ | 6/17/2025 | Johnson & JohnsonLaunches New TECNIS Odyssey Next-Generation Intraocular Lens in Europe, the Middle East, and Canada Offering Cataract Patients Precise Vision at Every Distance in Any Lighting*†‡1,6 | https://www.jnj.com/media-center/press-releases/johnson-johnson-launches-new-tecnis-odyssey-next-generation-intraocular-lens-in-europe-the-middle-east-and-canada-offering-cataract-patients-precise-vision-at-every-distance-in-any-lighting-1-6 |
| LLY | 6/17/2025 | Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk | https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-verve-therapeutics-advance-one-time-treatments |
| TSE:4578 | 6/17/2025 | Rejoin®, a digital treatment app for treating depression, is now on sale in the UK | https://www.otsuka.co.jp/company/newsreleases/2025/20250617_1.html |
| TSE:2269 | 6/16/2025 | Various "Meiji Bulgarian Yogurt" dining table that connects smiles - Limited-time Disney design packages available in order from late June / nationwide | https://www.meiji.co.jp/corporate/pressrelease/2025/06_05/ |
| TSE:3407 | 6/16/2025 | Announcement of the implementation of the "STOP Domino's Fracture Campaign" Osteoporosis Disease Awareness Activities - Starting a TV commercial featuring actor Yamaguchi Tomoko - | https://www.asahi-kasei.com/jp/news/2025/me250616.html |